The government has banned the manufacture, sale and distribution of 16 fixed-dose combination (FDC) drugs in India after a regulatory review found that these medicines did not have sufficient therapeutic justification, ET's Teena Thacker reported. The ban, which covers certain antibiotics, topical products, cosmetic formulations and other drug combinations, has come into effect immediately under Section 26A of the Drugs and Cosmetics Act, 1940.
